11.04.24 MDL numbers increased in November The GLP-1 MDL continued to grow, bringing the total number of cases in the docket to 1,221
Beyond documentation, supplier reputation matters significantly
Treatment Discontinuations The rate of treatment discontinuation due to adverse events is a critical metric for any chronic therapy
For each study included in the review, we extracted detailed information on the study design, sample size, participant characteristics, type and dosage of GLP-1 RA used, and the key outcomes measured
Dose-ranging studies are essential to determine optimal dosing regimens for different applications
In general, FOXC2 regulates developmental processes, metabolic processes, and during immune tolerance mediated by natural killer T cells (NKT)[63]